Nigel K. Arden

Nigel K. Arden

Auto-generated profile, based on publicly available information

Nigel K. Arden

Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
TMT.E. McAlindon
T.E. McAlindon
RBR.R. Bannuru
R.R. Bannuru
MSM.C. Sullivan
M.C. Sullivan
NAN.K. Arden
N.K. Arden
FBFrancis Berenbaum
Francis Berenbaum
MUM. Underwood
M. Underwood

1 February 2006 in Best Practice & Research Clinical Rheumatology
Verified
Journal Article
Closed access
NAN Arden
N Arden
MNM Nevitt
M Nevitt

28 October 2020 in Nature Reviews Rheumatology
Verified
Journal Article
Closed access
PDF file
NANigel K. Arden
Nigel K. Arden
TPThomas A. Perry
Thomas A. Perry
RBRaveendhara R. Bannuru
Raveendhara R. Bannuru
OBOlivier Bruyère
Olivier Bruyère
CCCyrus Cooper
Cyrus Cooper
JRJean-Yves Reginster
Jean-Yves Reginster

1 April 2015 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
DCD. Culliford
D. Culliford
JMJ. Maskell
J. Maskell
AJA. Judge
A. Judge
CCC. Cooper
C. Cooper
DPD. Prieto-Alhambra
D. Prieto-Alhambra
NAN.K. Arden
N.K. Arden

1 January 2010 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
PMPamela Mahon
Pamela Mahon
NHNicholas Harvey
Nicholas Harvey
SCSarah Crozier
Sarah Crozier
HIHazel Inskip
Hazel Inskip
SRSian Robinson
Sian Robinson
KGKeith Godfrey
Keith Godfrey
Recent findings suggest that maternal vitamin D insufficiency during pregnancy has consequences for the offspring's bone health in later life. To investigate whether maternal vitamin D insufficiency affects fetal femur growth in ways similar to those seen in childhood rickets and study the timing during gestation of any effect of maternal vitamin D status, we studied 424 pregnant women within a prospective longitudinal study of maternal nutrition and lifestyle before and during pregnancy (Southampton Women's Survey). Using high-resolution 3D ultrasound, we measured fetal femur length and distal metaphyseal cross-sectional area, together with the ratio of femoral metaphyseal cross-sectional area to femur length (femoral splaying index). Lower maternal 25-hydroxyvitamin vitamin D concentration was not related to fetal femur length but was associated with greater femoral metaphyseal cross-sectional area and a higher femoral splaying index at 19 weeks' gestation [r = −0.16, 95% confidence interbal (CI) −0.25 to −0.06 and r = −0.17, 95% CI −0.26 to −0.07, respectively] and at 34 weeks' gestation (r = –0.10, 95% CI −0.20 to 0.00 and r = −0.11, 95% CI −0.21 to −0.01, respectively). Three groups of women were identified with 25-hydroxyvitamin vitamin D concentrations that were sufficient/borderline (>50 nmol/L, 63.4%), insufficient (25 to 50 nmol/L, 30.7%), and deficient (≤25 nmol/L, 5.9%). Across these groups, the geometric mean femoral splaying indices at 19 weeks' gestation increased from 0.074 (sufficient/borderline) to 0.078 (insufficient) and 0.084 (deficient). Our observations suggest that maternal vitamin D insufficiency can influence fetal femoral development as early as 19 weeks' gestation. This suggests that measures to improve maternal vitamin D status should be instituted in early pregnancy. © 2010 American Society for Bone and Mineral Research

7 July 2011 in Arthritis & Rheumatism
Verified
Journal Article
Open access
PDF file
ANAlex S. Nicholls
Alex S. Nicholls
AKAmit Kiran
Amit Kiran
TPThomas C. B. Pollard
Thomas C. B. Pollard
DHDeborah J. Hart
Deborah J. Hart
CACharlotte P. A. Arden
Charlotte P. A. Arden
NANigel K. Arden
Nigel K. Arden
Objective: Subtle deformities of the hip joint are implicated in the etiology of osteoarthritis (OA) of the hip. Parameters that quantify these deformities may aid understanding of these associations. We undertook this study to examine relationships between such parameters and the 19‐year risk of total hip arthroplasty (THA) for end‐stage OA.Methods: A new software program designed for measuring morphologic parameters around the hip was developed and validated in a reliability study. THA was the outcome measure for end‐stage OA. A nested case–control study was used with individuals from a cohort of 1,003 women who were recruited at year 1 in 1989 and followed up to year 20 (the Chingford Study). All hips with THA by year 20 and 243 randomly selected control hips were studied. Pelvis radiographs obtained at year 2 were analyzed for variations in hip morphology. Measurements were compared between the THA case group and the control group.Results: Patients with THA had a higher prevalence of cam deformity than did their respective controls (median alpha angle 62.4° versus 45.8° [P = 0.001]; mean modified triangular index height 28.5 mm versus 26.9 mm [P = 0.001]) as well as a higher prevalence of acetabular dysplasia (mean lateral center edge angle 29.5° versus 34.3° [P = 0.001]; median extrusion index 0.25 versus 0.185 [P = 0.009]). Logistic regression analyses clustering by subject and adjusting for radiographic hip OA at year 2 showed that these morphologic parameters were still significantly associated with THA by year 20. The alpha angle and lateral center edge angle predicted the risk of THA independently when included in the same model.Conclusion: This investigation describes measurements that predict the risk of THA for end‐stage OA by year 20, independently of the presence of radiographic hip OA at year 2. These measurements can be made on an anteroposterior pelvis radiograph, which is an inexpensive and commonly used clinical method of investigation.